Phusjon Group

Advisory services for business
1 minute reading time (78 words)

Fraud & Corruption in the Pharmaceutical Industry in China

Fraud & Corruption Typologies

Despite increased enforcement of the US Foreign Corrupt Practices Act ("FCPA") and China's own commercial bribery laws, fraud and corruption remains rife across many industries in China, especially in the pharmaceutical and life sciences industry where the benefits of bribery still seem to outweigh the risks. The most common typologies being:  Sales teams bribing doctors to purchase their products
Fictitious sales and fake contracts
Tendering fraud and bid rigging
Off label use of pharmaceuticals
Forensic Integrity Due Diligence and the Protectio...
Bioplastics set for significant growth through 201...
 

Comments

No comments made yet. Be the first to submit a comment
Already Registered? Login Here
Guest
Wednesday, 27 October 2021
If you'd like to register, please fill in the username, password and name fields.